// App-Quantinova.ai

150 : Higher disease activity at baseline predicts disease progression and accrual of damage in Takayasu arteritis

Researchers

Presenter

  • Avinash Jain

Principal Investigators

  • Abhishek Zanwar

  • Durga P Misra

  • Ramnath Misra

  • Paul A Bacon

Medical Centers

  • Clinical Immunology and Rheumatology, SGPGIMS, Lucknow, INDIA

  • Rheumatology Research Group, College of Medicine, University of Birmingham, Birmingham, UNITED KINGDOM

Locations

  • India

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Takayasu arteritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A